In this study, we first established that PSO effectively inhibits OS cell proliferation, migration, and invasion in vitro and then demonstrated that it promotes OS cell apoptosis and inhibits OS tumor growth in vivo by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways. Here, AKT1 is linked to neoplasm.